唐夏林，女，1993年04月出生，湖南娄底人，医学博士，湖北省中医院脑病科住院医师。从事中医脑病科研与临床工作，主要研究方向为中医药防治缺血性卒中临床及基础研究，主持省自然及省中管局课题各1项，参与国自然课题3项，发表SCI论文8篇。

无

1、湖北省中医药管理局, 2023~2024年度中医药青年人才项目, ZY2023Q001, 黄芪甲苷调控m6A结合蛋白YTHDF1介导小胶质细胞表型转化保护脑缺血再灌注损伤的机制研究, 在研, 主持；

2、湖北省科学技术厅, 省自然科学基金青年项目, 2022CFB923, 川芎嗪调控YTHDF1介导 m6A甲基化调节小胶质细胞功能在脑缺血再灌注损伤中的机制研究, 在研, 主持；

1、国家自然科学基金委员会, 面上项目, 81873262, 芎芪合剂对于调控NMDA受体-调节神经突触在脑缺血-再灌注损伤中的机制研究, 结题, 参与；

2、国家自然科学基金委员会, 青年科学基金项目, 81804038, 芎芪有效配伍介导PKC调控紧密连接信号通路对溶栓后出血转化的作用与机制研究，结题, 参与；

3、国家自然科学基金委员会, 青年科学基金项目, 31800727, RNA解螺旋酶DDX5在抗病毒天然免疫反应中的调控作用及分子机制研究，结题, 参与。

1、Xialing Tang#; Shanshan Xie#; Huajun Wang#; Yingbin Li#; Zhiyu Lai; Shuangxi Sun; Ruanhuan Pan; Yan Huang; Jun Cai.The combination of Astragalus membranaceus and ligustrazine mitigates cerebral ischemia‐reperfusion injury via regulating NR2B‐ERK/CREB signaling, Brain and Behavior, 2023, 13(2)；

2、Pan, Ruihuan#; Tang, Xialin#; Wang, Huajun; Huang, Yan; Huang, Kai; Ling, Shanshan; Zhou,Mingchao; Cai, Jun; Chen, Hongxia.The Combination of Astragalus membranaceus and Ligustrazine Protects Against Thrombolysis-Induced Hemorrhagic Transformation Through PKC delta/Marcks Pathway in Cerebral Ischemia Rats, Cell Transplantation, 2020, 29: 0-0963689720946020    

3、Tang, Xialin; Wang, Huajun; Chen, Huihuan; Sun, Shuangxi; Chen, Hongxia; Pan, Ruihuan .Protective Effects of Astragalus Membranaceus and Ligustrazine on Rat Brain Microvascular Endothelial Cell Injury after Oxygen-Glucose Deprivation/Reoxygenation by Suppressing the PKCd/MARCKS Pathway, Combinatorial Chemistry & High Throughput Screening, 2021, 24(7): 947-956     

4、Wang, Hua-Jun#; Tang, Xia-Lin#; Huang, Gan; Li, Ying-Bin; Pan, Rui-Huan; Zhan, Jie; Wu, Ye-Kun; Liang, Jian-Feng; Bai, Xiao-xin; Cai, Jun. Long Non-Coding KCNQ1OT1 Promotes Oxygen-Glucose- Deprivation/Reoxygenation-Induced Neurons Injury Through Regulating MIR-153-3p/FOXO3 Axis, Journal of Stroke and Cerebrovascular Diseases, 2020, 29(10): 0-105126

5、Zheng, Linbo; Tang, Xialin; Lu, Minyi; Sun, Shuangxi; Xie, Shanshan; Cai, Jun; Zan, Jie .microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation, International Immunopharmacology,2020, 88: 0-106937   

6、Zan Jie；Xu Ruixian ; Tang Xialin；Minyi Lu；Shanshan Xie；Jun Cai；Zhi Huang；Jinyang Zhang. RNA helicase DDX5 suppresses IFN-I antiviral innate immune response by interacting with PP2A-Cβto deactivate IRF3.EXPERIMENTAL CELL RESEARCH.2020;396 (2)：112332.

7、Zhang, Xin-Chun; Gu, Ai-Ping; Zheng, Chun-Ye; Li, Ying-Bin; Liang,Hong-Feng; Wang, Hua-Jun; Tang, Xia-Lin; Bai, Xiao-Xin; Cai, Jun. YY1/LncRNA GAS5 complex aggravates cerebral ischemia/reperfusion injury through enhancing neuronal glycolysis, Neuropharmacology, 2019, 158: 0-107682

8、Ruihuan Pan；Mingchao Zhou；Yiping Zhong；Jingping Xie；Shanshan Ling；Xialin Tang, Yan Huang and Hongxia Chen. The combination of Astragalus membranaceus extract and ligustrazine to improve the inflammation in rats with thrombolytic cerebral ischemia[J]. International journal of immunopathology and pharmacology. 2019,33:2058738419869055

2020年获博士研究生国家奖学金；

2021年获校优秀毕业生；

2022年获湖北省中医院年度“科研工作先进个人”